688658 悦康药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额430,486785,492(121,169)515,239697,665
投资活动产生之现金流量净额(320,111)(502,047)(556,545)(200,836)(190,725)
筹资活动产生之现金流量净额(3,255)(432,192)(101,604)(408,276)1,636,018
汇率变动对现金及现金等价物的影响5033,9366,203(913)(1,368)
现金及现金等价物净增加/(减少)107,622(144,812)(773,115)(94,786)2,141,591
期初现金及现金等价物余额1,373,5331,518,3452,291,4602,386,246244,655
期末现金及现金等价物余额1,481,1551,373,5331,518,3452,291,4602,386,246